|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,742.00 MXN | +0.62% |
|
+0.62% | +9.68% |
| 07-13 | Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy | MT |
| 07-13 | Wall Street's Stress Test Arrives |  |
| Market Cap | 281B 4,912B 246B 228B 210B 397B 26,869B 405B 2,718B 1,066B 13,195B 1,054B 1,031B 45,568B | P/E 2026 * |
21.4x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 313B 5,473B 274B 254B 234B 442B 29,934B 451B 3,028B 1,188B 14,700B 1,174B 1,149B 50,766B | EV / Sales 2026 * |
5.5x | EV / Sales 2027 * | 5.13x |
| Free-Float |
91.66% | Yield 2026 * |
2.87% | Yield 2027 * | 2.97% |
Last Transcript: Novartis AG
| 1 day | +0.62% | ||
| 1 week | +0.62% | ||
| Current month | +0.62% | ||
| 1 month | +5.42% | ||
| 3 months | +2.81% | ||
| 6 months | +7.28% | ||
| Current year | +9.68% |
| 1 month | 2,563 |  | 2,742 |
| Current year | 2,479 | | 2,866.83 |
| 1 year | 2,206 | | 2,866.83 |
| 3 years | 1,540 | | 2,866.83 |
| 5 years | 1,520 | | 2,866.83 |
| 10 years | 1,320.81 | | 2,866.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.62% | +0.62% | - | - | 282B | |
| -0.56% | -1.52% | +49.04% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.29% | +62.31% | 619B | |
| -0.03% | -2.65% | +28.86% | +85.64% | 438B | |
| -1.75% | -0.33% | +28.78% | +23.58% | 333B | |
| -1.75% | -10.57% | +20.67% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.10% | -37.96% | 218B | |
| -0.81% | -1.63% | +22.07% | +58.33% | 196B | |
| +1.21% | +1.38% | +19.85% | +71.29% | 161B | |
| +1.28% | +3.20% | -4.56% | -32.11% | 138B | |
| Average | -0.03% | -1.66% | +22.54% | +47.23% | 381.08B | |
| Weighted average by Cap. | -0.18% | -1.84% | +35.19% | +82.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.85B 995B 49.86B 46.18B 42.49B 80.37B 5,441B 81.94B 550B 216B 2,672B 213B 209B 9,228B | 60.27B 1,055B 52.86B 48.96B 45.05B 85.21B 5,769B 86.87B 584B 229B 2,833B 226B 221B 9,783B |
| Net income | 14.08B 246B 12.35B 11.44B 10.52B 19.9B 1,348B 20.29B 136B 53.46B 662B 52.87B 51.71B 2,285B | 15.64B 274B 13.72B 12.71B 11.69B 22.12B 1,497B 22.55B 151B 59.4B 735B 58.74B 57.46B 2,539B |
| Net Debt | 32.03B 560B 28.09B 26.02B 23.94B 45.28B 3,065B 46.16B 310B 122B 1,505B 120B 118B 5,198B | 28.54B 499B 25.03B 23.18B 21.33B 40.35B 2,731B 41.13B 276B 108B 1,341B 107B 105B 4,632B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NVS N Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
